Treatment of Hypothyroid Patients With L-Thyroxine (L-T4) Plus Triiodothyronine Sulfate (T3S). A Phase II, Open-Label, Single Center, Parallel Groups Study on Therapeutic Efficacy and Tolerability

Sodium salt of levothyroxine (L-T4) is the treatment of choice of hypothyroidism. Yet, L-T4 monotherapy produces supoptimal 3,5,3′-triiodothyronine (T3)/T4 ratio in serum, as compared to normal subjects, and a minority of hypothyroid individuals on L-T4 complain for an incomplete well-being. Orally...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Endocrinol (Lausanne)
Autori principali: Santini, Ferruccio, Ceccarini, Giovanni, Pelosini, Caterina, Giannetti, Monica, Ricco, Ilaria, Querci, Giorgia, Grossi, Enzo, Saponati, Giorgio, Vitti, Paolo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896827/
https://ncbi.nlm.nih.gov/pubmed/31849843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00826
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi